Kurt Gunter, MD, M.D

Rare Disease / Clinical Research

Inozyme Pharma, Inc.

BEVERLY, MA

PI on 8 trialsNPI: 1720107964

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Epstein-Barr virus-positive diffuse large B-cell lymphoma
Calciphylaxis cutis
Post-transplant lymphoproliferative disease
Calciphylaxis
Generalized arterial calcification of infancy
Autosomal recessive hypophosphatemic rickets

Clinical trials (8)

NCT06462547
NCT05050669
NCT06283589
NCT05030831
NCT06046820
NCT00089596
NCT04686175
NCT02763254

Verify independently

ClinicalTrials.gov PI search for Kurt Gunter, MD
NPPES NPI registry entry

Other specialists for Epstein-Barr virus-positive diffuse large B-cell lymphoma

Peers ranked by clinical-trial PI role, publications, and verification quality.

Ajay Gopal
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
WA
Colleen Delaney, MD
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
CT
Jennifer Crombie, MD, M.D
Dana-Farber Cancer Institute
MA
Karen Syrjala
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
WA
Paul Martin
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Nancy Wells, DNSc, RN
Vanderbilt-Ingram Cancer Center
Philip L. McCarthy, MD
Roswell Park Cancer Institute
Mary Laughlin, MD
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

See all specialists for Epstein-Barr virus-positive diffuse large B-cell lymphoma →

← Back to specialists directory